Mammalian-transmissible H5N1 influenza: the dilemma of dual-use research
1Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. robert.webster@stjude.org
Abstract:
The National Science Advisory Board for Biosecurity (NSABB)'s recommendation to restrict publication of the details of the generation of mammalian-transmissible H5N1 influenza virus is unprecedented. Dual-use considerations indicated that the potential biosecurity risks of a transmissible H5N1 virus with a possible mortality of 50% in humans outweigh the substantial benefits of open and complete scientific exchange in this case, although the benefits include potential early detection strategies for H5N1 viruses with specific genetic markers and control strategies, including development of antivirals and vaccines. It is argued that both the funding agency (the National Institute of Allergy and Infectious Diseases) and the scientists were responding to societal needs and acted entirely responsibly. These studies usher in a new era for life sciences, compelling the research community to confront important decisions: under what conditions should such research be done? How can the principle of full release of information be balanced with the moral imperative to protect the public health?
Insights
The National Science Advisory Board for Biosecurity recommended restricting H5N1 influenza virus research publication due to biosecurity risks. This decision balances scientific openness with public health protection in a new era of life sciences research.
Area of Science:
- Virology
- Biosecurity
- Public Health Policy
Background:
- The National Science Advisory Board for Biosecurity (NSABB) addressed the publication of research on mammalian-transmissible H5N1 influenza virus.
- Dual-use research concerns were raised regarding the potential risks and benefits of disseminating such findings.
Purpose of the Study:
- To evaluate the NSABB's recommendation to restrict publication of H5N1 research.
- To analyze the balance between scientific transparency and biosecurity imperatives.
Main Methods:
- Review of NSABB's recommendation and dual-use considerations.
- Analysis of potential risks (e.g., 50% human mortality) versus benefits (e.g., vaccine development).
Main Results:
- NSABB recommended restricting publication due to significant biosecurity risks outweighing immediate scientific benefits.
- The decision acknowledges potential benefits like early detection and control strategies for H5N1.
Conclusions:
- The research ushers in a new era for life sciences, necessitating careful consideration of research conditions.
- Balancing the principle of full information release with public health protection is a critical challenge for the research community.
Related Concept Videos
Viral Recombination
Leaky Scanning
Viral Mutations


